Outcomes of Older Patients with NPM1 Mutated and FLT3-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation

Ítems similars

• Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation
  per: Grimm, Juliane, et al.
  Publicat: (2020)
• ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation
  per: Jentzsch, Madlen, et al.
  Publicat: (2020)
• Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML
  per: Jentzsch, Madlen, et al.
  Publicat: (2020)
• Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation
  per: Jentzsch, Madlen, et al.
  Publicat: (2021)
• High expression of the stem cell marker GPR56 at diagnosis identifies acute myeloid leukemia patients at higher relapse risk after allogeneic stem cell transplantation with the CD34(+)/CD38(-) population
  per: Jentzsch, Madlen, et al.
  Publicat: (2020)